Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,377 | -5,361 | -3,277 | -944 | -5,259 |
| Depreciation Amortization | 505 | 291 | 195 | 114 | 201 |
| Other Working Capital | -615 | -579 | -385 | -19 | -408 |
| Other Operating Activity | 5,501 | 3,250 | 2,033 | 310 | 3,657 |
| Operating Cash Flow | $-2,986 | $-2,399 | $-1,434 | $-540 | $-1,809 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -1,209 | -1,179 | -666 | 0 | 0 |
| Investing Cash Flow | $-1,209 | $-1,179 | $-666 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | N/A | 412 | 30 |
| Debt Issued | 889 | 159 | 9 | N/A | 942 |
| Debt Repayment | -427 | -277 | N/A | N/A | -327 |
| Common Stock Issued | 4,297 | 3,769 | 2,450 | N/A | 1,373 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -7 |
| Other Financing Activity | -120 | -90 | -103 | 17 | -29 |
| Financing Cash Flow | $4,638 | $3,560 | $2,356 | $429 | $1,981 |
| Exchange Rate Effect | 20 | 8 | -44 | 7 | -25 |
| Beginning Cash Position | 864 | 864 | 864 | 864 | 717 |
| End Cash Position | 1,327 | 854 | 1,076 | 760 | 864 |
| Net Cash Flow | $463 | $-10 | $213 | $-104 | $147 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,986 | -2,399 | -1,434 | -540 | -1,809 |
| Free Cash Flow | -2,986 | -2,399 | -1,434 | -540 | -1,809 |